Metastatic Prostate Adenocarcinoma
Showing 1 - 22 of 22
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2023
Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)
Not yet recruiting
- Prostate Cancer
- +11 more
- Guided physical exercise
- +2 more
-
Tampere, Länsi-Suomi, FinlandTampere University Hospital
Apr 3, 2023
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Atlanta
Not yet recruiting
- Castration-Sensitive Prostate Carcinoma
- +2 more
- Abiraterone
- +9 more
-
Atlanta, Georgia
- +1 more
Feb 8, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Abiraterone Acetate/Niraparib
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 9, 2023
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in United
Recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Laboratory Biomarker Analysis
- +3 more
-
La Jolla, California
- +21 more
Dec 2, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +5 more
- Questionnaire Administration
- Tin Sn 117m Pentetate
-
Lexington, KentuckyUniversity of Kentucky/Markey Cancer Center
Nov 26, 2022
Tumor Molecular Profiling in Patients With Prostate Cancer
Completed
- Prostate Cancer
- Metastatic Prostate Adenocarcinoma
- Tumor molecular profiling
-
Athens, GreeceHellenic Cooperative Oncology Group
Oct 17, 2022
Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen
Recruiting
- Castration-Resistant Prostate Carcinoma
- +7 more
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
-
San Francisco, California
- +1 more
Sep 20, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San
Recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Abemaciclib
- Lutetium Lu 177-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2022
Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Atlanta (VLP-encapsulated TLR9 Agonist CMP-001,,
Not yet recruiting
- Metastatic Prostate Adenocarcinoma
- Stage IV Prostate Cancer AJCC v8
- VLP-encapsulated TLR9 Agonist CMP-001,
- Nivolumab
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 26, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer American Joint Committee
Recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Aug 1, 2022
Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)
Terminated
- Metastatic Prostate Adenocarcinoma
- +3 more
-
Boston, Massachusetts
- +2 more
Jul 18, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory
Active, not recruiting
- Castration Levels of Testosterone
- +9 more
- Recombinant EphB4-HSA Fusion Protein
-
Los Angeles, California
- +2 more
Apr 4, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Salt Lake
Recruiting
- Castration-Resistant Prostate Carcinoma
- +4 more
- Atezolizumab
- Cabozantinib S-malate
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Mar 11, 2022
Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Prostate Cancer Trial in San Antonio (High Intensity
Recruiting
- Prostate Cancer Metastatic
- +3 more
- High Intensity Interval Training
-
San Antonio, TexasUT Health San Antonio
Feb 17, 2022
Metastatic Prostate Adenocarcinoma Trial in New York (68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator)
Completed
- Metastatic Prostate Adenocarcinoma
- 68Ga-PSMA-cyclotron Versus 68Ga-PSMA-generator
-
New York, New YorkWeill Cornell Medicine
Feb 1, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +4 more
- Educational Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 13, 2021
Observatory of Metastatic ProstAte Adenocarcinoma That is
Recruiting
- Metastatic Prostate Adenocarcinoma
- Local chemotherapy
-
Rouen, FranceRouen University Hospital
Nov 5, 2019